Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy

Our recent findings strongly support the idea of PLAC1 being as a potential immunotherapeutic target in prostate cancer (PCa). Here, we have generated and evaluated an anti-placenta-specific1 (PLAC1)-based antibody drug conjugate (ADC) for targeted immunotherapy of PCa. Prostate cancer cells express...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Nejadmoghaddam, Mohammad-Reza, Zarnani, Amir-Hassan, Ghahremanzadeh, Ramin, Ghods, Roya, Mahmoudian, Jafar, Yousefi, Maryam, Nazari, Mahboobeh, Ghahremani, Mohammad Hossein, Abolhasani, Maryam, Anissian, Ali, Mahmoudi, Morteza, Dinarvand, Rassoul
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5645454/
https://ncbi.nlm.nih.gov/pubmed/29042604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-13682-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars